CRYOSTAT-2: Early Empiric Cryoprecipitate in Major Trauma
RebelEM
OCTOBER 30, 2023
This could dilute any beneficial effects seen Lack of blinding may bias results (Although mortality is a solid objective primary outcome, bias may still creep in terms of management) Discussion: Authors were looking for an absolute mortality difference of 7% from baseline mortality of 26% with a 90% power. Cryoprecipitate Group: 25.3%
125 
Let's personalize your content